On November 20, 2022, a panel of the Inquiry Committee approved a Consent Agreement under which the Registrant agreed to undertakings involving regular monitoring for fitness to practice nursing and a limit on practice. The concerns giving rise to the complaint included the Registrant diverting medication including narcotics from the employer and falsification of records in order to conceal the diversion activities. The terms of the Consent Agreement includes but is not limited to:
- Regular reports from medical monitor regarding compliance with biological testing;
- Disclosure of treatment recommendations to relevant employer representative(s); and
- A limit on practice designed to prevent the circumstances leading to the practice concern from reoccurring.
The Agreement will remain in place for a minimum of three years of continuous nursing practice.
The reasons for the Inquiry Committee decision are as follows:
- The Registrant provided an independent medical assessment documenting health concerns to BCCNM which could impact their ability to provide safe patient care; and
- The independent medical assessment identified the Registrant is fit to practice nursing, and they provided information regarding compliance with treatment recommendations.
The name of the Registrant has been withheld in accordance with section 39.3 (4) (a) of the Health Professions Act for the purposes of not identifying the personal health information of the Registrant respecting the condition.
The Inquiry Committee is satisfied that the terms will protect the public.